Michael Morris, MD
@mjmorrismd.bsky.social
Medical Oncologist and Prostate Cancer Section Head at Memorial Sloan Kettering Cancer Center.
Welcome, Toni - we are all the better for your arrival!
November 30, 2024 at 12:53 PM
Welcome, Toni - we are all the better for your arrival!
Agree - EMBARK doesn’t speak to this issue. The GOC of salvage RT is cure. The GOC of EMBARK is MFS. Different contexts and purposes; both have a role in helping pts with BCR #ProstateCancer.
November 29, 2024 at 2:53 PM
Agree - EMBARK doesn’t speak to this issue. The GOC of salvage RT is cure. The GOC of EMBARK is MFS. Different contexts and purposes; both have a role in helping pts with BCR #ProstateCancer.
Nice point. Also, a negative trial isn’t a failed study if successfully completed and well designed with a clear readout. It’s just….negative.
November 25, 2024 at 8:00 PM
Nice point. Also, a negative trial isn’t a failed study if successfully completed and well designed with a clear readout. It’s just….negative.
We share your pride!
November 24, 2024 at 2:09 AM
We share your pride!
Outstanding article and beautifully written.
November 24, 2024 at 2:06 AM
Outstanding article and beautifully written.
Thanks for doing this!
November 24, 2024 at 12:56 AM
Thanks for doing this!